Strongbridge Biopharma plc Operating Income

Strongbridge Biopharma plc (SBBP) currently reports a operating income of $-43M as of June 2021. That compares with $-54M in the prior-year period — up 19.4% year over year. Use the charts on this page to explore Strongbridge Biopharma plc's operating income history and peer comparisons.

Strongbridge Biopharma plc's operating income increased from $-54M to $-43M — a 19.4% year-over-year increase (period ending June 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Strongbridge Biopharma plc reported $-43M in operating income as of June 2021. That compares with $-54M in the prior-year period — up 19.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-43M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Strongbridge Biopharma plc, and consider following SBBP for alerts when major investors trade the stock.

Strongbridge Biopharma plc is classified in the Healthcare sector. On operating income, it currently shows $-43M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SBBP with unrelated industries.